Nano Labs Ltd (NA) Stock Price & Analysis
Nano Labs Ltd (NA) closed at USD 1.66 on Friday, October 23, 2026, down 1.49% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 1.66; the Oct 23, 2026 session ranged USD 1.66–1.74 on volume of 21,631 shares. Market capitalization is —, with a 52-week range of USD 1.58–5.16 (NGM). Source: Nexqual, retrieved October 24, 2026 at 15:48 UTC.
Also available as compact Markdown for AI agents: nexqual.com/NA.md
Key facts (NA)
- Insider open-market sales, last ~7 months: 8 Form 4 filings, $85K; 8 not under a Rule 10b5-1 plan ($85K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Total return with dividends: 1Y -66.0% vs S&P 500 +13.4%; 5Y -97.6% vs S&P 500 +76.9%.
- Next earnings: 2026-08-28, EPS estimate USD —, revenue estimate $0K.
Insider sales (SEC Form 4, open-market, last ~7 months) (NA)
0 of 8 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | Hu Nan | Director | 11,165 | $25K | 28.8% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-28 | Hu Nan | Director | 4,352 | $9K | 10.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-27…2026-04-28 | Hu Nan | Director | 6,148 | $13K | 12.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-20 | Hu Nan | Director | 4,092 | $11K | 7.7% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-17 | Hu Nan | Director | 1,633 | $5K | 3% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-16 | Hu Nan | Director | 3,900 | $12K | 6.6% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-15 | Hu Nan | Director | 893 | $3K | 1.5% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-04-15 | Hu Nan | Director | 2,557 | $8K | 4.1% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Total return (dividends reinvested) (NA)
| 1Y (from 2025-10-24) | 5Y (from 2022-07-11) | |
|---|---|---|
| Total return | -66.0% | -97.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | -66.1% | -58.0% |
| Volatility (annualized) | 88.9% | 136.8% |
| Max drawdown | -68.2% (Nov 2025→Apr 2026) | -98.3% (Jul 2022→May 2026) |
NA suppliers, customers and competitors (named in its 20-F)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Competitor | Broadcom (AVGO) | “In terms of smart-NICs, we expect to face competition from industry giants such as Broadcom and Intel as well as other existing and new” |
| Competitor | Intel (INTC) | “In terms of smart-NICs, we expect to face competition from industry giants such as Broadcom and Intel as well as other existing and new” |
Quoted from the company's 20-F filed Apr 13, 2026.
Companies that name NA in their SEC reports
| Relationship to NA | Company | Filing | Sentence |
|---|---|---|---|
| partner | The9 LTD (NCTY) | 20-F Apr 16, 2026 | “In July 2022, the Group made a RMB 20.2 million (US$3 million) strategic investment in the initial public offering of Nano Labs to obtain of 260,642 American depositary shares ("ADSs") of Nano Labs.” |
NA analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter | — | — | — | $0 | — |
| Next quarter | — | — | — | $0 | — |
| Current fiscal year | — | — | — | $0 | — |
| Next fiscal year | — | — | — | $0 | — |
NA options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 27 | 210.1% | ±68.7% |
| Feb 19, 2027 | 118 | 107.2% | ±85.8% |
| May 21, 2027 | 209 | 227.6% | ±144.6% |
30-day implied volatility 128.7% vs 67.4% realized over the last 30 trading days. Put/call ratio (volume) —. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 24, 2026 at 15:48 UTC)
| Price | USD 1.66 |
|---|---|
| Change | ▼ 1.49% (down) |
| Previous Close | USD 1.66 |
| Open | USD 1.66 |
| Day Range | USD 1.66 – 1.74 |
| 52-Week Range | USD 1.58 – 5.16 |
| Volume | 21,631 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (NA)
Nexqual's technical model rates NA "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 24, 2026 at 15:48 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.85 (neutral) |
| vs SMA50 | Below (USD 2.1) |
| MACD | -0.12 (negative) |
Earnings (NA)
| Next Earnings Date | 2026-08-28 |
|---|
Source: Nexqual, October 24, 2026 at 15:48 UTC.
Financials & Fundamentals (NA)
| Total Revenue | $21.50M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -66.50% |
| Gross Margin | -10.66% |
| Operating Margin | -1483.94% |
| Profit Margin | +0.00% |
| ROE | -35.63% |
| Debt / Equity | 0.59 |
| Current Ratio | 1.2 |
| Total Cash | $15.05M |
| Total Debt | $229.13M |
Source: Nexqual, October 24, 2026 at 15:48 UTC.
Ownership (NA)
| Insider Ownership | +56.04% |
|---|---|
| Institutional Ownership | +42.65% |
| Shares Outstanding | 20.36M |
| Float | 8.42M |
| Short % of Float | +8.01% |
Source: Nexqual, October 24, 2026 at 15:48 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BGLC | BioNexus Gene Lab Corp | USD 1.19 | ▼ 0% |
| ILAG | Intelligent Living Application | USD 2.47 | ▼ 2.37% |
| SVRE | SaverOne 2014 Ltd. | USD 1.22 | ▼ 15.28% |
| MGIH | Millennium Group International | USD 1.32 | ▼ 0.38% |
| TGL | Treasure Global Inc. | USD 0.22 | ▼ 6.54% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 15:48 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt